Immatics (IMTX) Non Operating Income (2019 - 2025)
Immatics (IMTX) reported Non Operating Income of $3.9 million for Q4 2025, down 91.47% on a YoY basis from $45.3 million in Q4 2024, and down 16.62% sequentially from $4.6 million in Q3 2025.
Immatics (IMTX) Non Operating Income (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Non Operating Income data on file, last reported at $3.9 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 91.47% year-over-year to $3.9 million; the trailing twelve-month figure through Dec 2025 stood at -$17.9 million (down 127.84% YoY), and the FY2025 full-year result was -$18.6 million, down 128.59% from the prior year.
- Non Operating Income slipped to $3.9 million in Q4 2025, from $4.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $45.3 million in Q4 2024 to a low of -$20.6 million in Q2 2025.
- A 5-year average of $2.9 million and a median of $1.6 million in 2022 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income tumbled 1182.94% in 2022 and soared 2587.02% in 2024, its largest moves.
- Tracing IMTX's Non Operating Income over 5 years: stood at -$831666.9 in 2021, then plunged by 1182.94% to -$10.7 million in 2022, then soared by 115.79% to $1.7 million in 2023, then soared by 2587.02% to $45.3 million in 2024, then sank by 91.47% to $3.9 million in 2025.
- Business Quant data shows IMTX's Non Operating Income at $3.9 million in Q4 2025, $4.6 million in Q3 2025, and -$20.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.86 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | -20.63 Mn |
| Mar 31, 2025 | -5.76 Mn |
| Dec 31, 2024 | 45.27 Mn |
| Sep 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | 9.38 Mn |
| Mar 31, 2024 | 12.76 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | -11.21 Mn |
| Mar 31, 2023 | 7.17 Mn |
| Dec 31, 2022 | -10.67 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 4.08 Mn |
| Mar 31, 2022 | 19.27 Mn |
| Dec 31, 2021 | -831,666.88 |
| Sep 30, 2021 | -4.96 Mn |
| Jun 30, 2021 | -3.78 Mn |
| Mar 31, 2021 | 1.24 Mn |